Two Contrasting Interventions for Sleep Management
Completed · Phase 2/Phase 3
Conditions studied: Primary Insomnia, Secondary Insomnia
In brief
This study will determine whether Mind-Body Bridging (MBB), a mindfulness training program is more effective than a common sleep medication, Zolpidem, in treating insomnia. It will also investigate whether MBB is additionally beneficial for co-morbid conditions such as stress, PTSD, depression, etc, compared with that of Zolpidem.
Key facts
- Study ID
- NCT01804036
- Run by
- University of Utah
- People needed
- 72
- Starts
- 2013-03-01
- Expected to finish
- 2016-11-01
- Last updated by the study team
- 2017-03-30
Who can join
Age: 17 and older, up to 40. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- primary insomnia
- secondary insomnia
- requiring sleep medication (Zolpidem) for a three-week trial.
- active duty military service member stationed at Fort Carson.
You may not qualify if…
- secondary insomnia to a likely medical condition, such as sleep apnea, chronic obstructive pulmonary disease, restless leg syndrome, and other sleep disorders, which are not appropriately treatable with sleep medication.
- treated for sleep problems using sleep medications which include Lunesta, Ambien, Ambien Controlled Release (CR), Seroquel, Trazodone or Remeron
- major psychopathology (i.e., schizophrenia)
- severe depression within the past 90 days
- suicidal ideation within the past 90 days
- psychiatrically hospitalized within the past 90 days
- uncontrolled hypertension or diabetes
- pregnancy
- previous use of Zolpidem proved to be ineffective or to cause other unwanted side effects
- actively abusing controlled substances
- enrolled in another study
Where it is running
- Evans Army Community Hospital — Colorado Springs, Colorado, United States
- University of Utah — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.